Inventor · disambiguated record
Gordon Saxty
Also filed as: SAXTY GORDON
42 granted patents·14 pending applications·431 citations·filing 2003–2024
98Inventor score
Files withASTEX THERAPEUTICS LTD30SAXTY GORDON10BERDINI VALERIO6GALAPAGOS NV2GLAXOSMITHKLINE IP DEV LTD2
Top patents by PatentIndex Score
56 records- 0195US9850228B2Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2016·Granted Dec 26, 2017·17 cites·5 claims
- 0295US9464071B2Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2014·Granted Oct 11, 2016·24 cites·45 claims
- 0395US9447098B2Pteridines as FGFR inhibitorsASTEX THERAPEUTICS LTD·Filed 2013·Granted Sep 20, 2016·35 cites·20 claims
- 0494US9309242B2Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2012·Granted Apr 12, 2016·26 cites·28 claims
- 0594US9303029B2Substituted quinoxalines as FGFR kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2012·Granted Apr 5, 2016·25 cites·20 claims
- 0694US8895601B2Pyrazolyl quinoxaline kinase inhibitorsSAXTY GORDON·Filed 2011·Granted Nov 25, 2014·25 cites·36 claims
- 0793US11225476B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2020·Granted Jan 18, 2022·3 cites·13 claims
- 0893US9856236B2Substituted quinoxalines as FGFR kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2015·Granted Jan 2, 2018·16 cites·20 claims
- 0993US9439896B2Quinolines as FGFR kinase modulatorsASTEX THERAPEUTICS LTD·Filed 2012·Granted Sep 13, 2016·22 cites·20 claims
- 1093US9290478B2Substituted quinoxalines as FGFR kinase inhibitorsSAXTY GORDON·Filed 2011·Granted Mar 22, 2016·25 cites·20 claims
- 1192US10052320B2Substituted quinoxalines as FGFR kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2016·Granted Aug 21, 2018·11 cites·20 claims
- 1292US10045982B2Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2016·Granted Aug 14, 2018·11 cites·33 claims
- 1392US10039759B2Quinolines as FGFR kinase modulatorsASTEX THERAPEUTICS LTD·Filed 2016·Granted Aug 7, 2018·11 cites·21 claims
- 1492US9617248B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2013·Granted Apr 11, 2017·10 cites·20 claims
- 1592US8895745B2Bicyclic heterocyclic compounds as FGFR inhibitorsBERDINI VALERIO·Filed 2007·Granted Nov 25, 2014·33 cites·20 claims
- 1691US9980973B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2017·Granted May 29, 2018·6 cites·21 claims
- 1791US9783538B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2014·Granted Oct 10, 2017·12 cites·53 claims
- 1890US11643410B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2021·Granted May 9, 2023·1 cites·22 claims
- 1990US10519137B2Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2017·Granted Dec 31, 2019·6 cites·18 claims
- 2090US8071614B2Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitorsSAXTY GORDON·Filed 2008·Granted Dec 6, 2011·16 cites·12 claims
- 2189US8481531B2Bicyclic heterocyclyl derivatives as FGFR kinase inhibitors for therapeutic useSAXTY GORDON·Filed 2010·Granted Jul 9, 2013·9 cites·20 claims
- 2289US2025296930A1Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 2387US10618895B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2017·Granted Apr 14, 2020·4 cites·33 claims
- 2487US8131527B1FGFR pharmacophore compoundsSAXTY GORDON·Filed 2007·Granted Mar 6, 2012·17 cites·47 claims
- 2587US8076354B2Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitorsSAXTY GORDON·Filed 2008·Granted Dec 13, 2011·9 cites·13 claims
- 2686US9617283B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2013·Granted Apr 11, 2017·10 cites·20 claims
- 2785US10272087B2Pteridines as FGFR inhibitorsASTEX THERAPEUTICS LTD·Filed 2016·Granted Apr 30, 2019·5 cites·21 claims
- 2884US12202828B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2022·Granted Jan 21, 2025·0 cites·48 claims
- 2984US9663512B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2013·Granted May 30, 2017·8 cites·18 claims
- 3084US8859582B2Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitorsSAXTY GORDON·Filed 2011·Granted Oct 14, 2014·7 cites·20 claims
- 3183US8513276B2Imidazo[1,2-a]pyridine compounds for use in treating cancerBERDINI VALERIO·Filed 2007·Granted Aug 20, 2013·8 cites·16 claims
- 3280US8546407B2Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitorsBERDINI VALERIO·Filed 2005·Granted Oct 1, 2013·4 cites·18 claims
- 3377US2022135544A1Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 3476US9006430B2Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as proteinASTEX THERAPEUTICS LTD·Filed 2014·Granted Apr 14, 2015·2 cites·20 claims
- 3576US8691806B2Pyrazole derivatives as protein kinase modulatorsBERDINI VALERIO·Filed 2012·Granted Apr 8, 2014·2 cites·20 claims
- 3675US8809336B2Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitorsASTEX THERAPEUTICS LTD·Filed 2013·Granted Aug 19, 2014·2 cites·13 claims
- 3773US8796244B2Imidazopyridine derivatives as inhibitors of receptor tyrosine kinasesBERDINI VALERIO·Filed 2009·Granted Aug 5, 2014·2 cites·21 claims
- 3873US8247576B2Pyrazole derivatives as protein kinase modulatorsBERDINI VALERIO·Filed 2004·Granted Aug 21, 2012·5 cites·8 claims
- 3968US10919910B2Seco macrolide compoundsFIDELTA D O O·Filed 2017·Granted Feb 16, 2021·2 cites·26 claims
- 4068US2020131153A1Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 4162US9283226B2Pyrazole derivatives as protein kinase modulatorsASTEX THERAPEUTICS LTD·Filed 2014·Granted Mar 15, 2016·0 cites·20 claims
- 4258US2022169653A1Pyrrolopyrimidine and pyrrolopyridine derivativesGALAPAGOS NV·Filed 2021·Application pending·0 cites
- 4358US2024239744A12-(3-ethynylbenzyl)-substituted heterocycle derivatives and related usesOREXIA THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 4455US2023331720A1Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and their uses as orexin-2 receptor agonistsOREXIA THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 4553US2016250187A1Pyrazole derivatives as protein kinase modulatorsASTEX THERAPEUTICS LTD·Filed 2016·Application pending·0 cites
- 4652US11136325B2Pyrrolopyrimidine and pyrrolopyridine derivativesGALAPAGOS NV·Filed 2018·Granted Oct 5, 2021·0 cites·14 claims
- 4750US2019002454A1NRF2 RegulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Application pending·0 cites
- 4849US8859583B2Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitorsSAXTY GORDON·Filed 2011·Granted Oct 14, 2014·0 cites·20 claims
- 4948US11512096B2Seco macrolide compoundsSELVITA D O O·Filed 2020·Granted Nov 29, 2022·0 cites·20 claims
- 5045US2006135589A11h-Indazole-3-carboxamide compounds as cyclin dependent kinase (cdk) inhibitorsASTEX TECHNOLOGY INC·Filed 2003·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →